meningococcemia masquerading as a nonspecific flu-like...

4
Case Report Meningococcemia Masquerading as a Nonspecific Flu-Like Syndrome Paula J. Watts , 1,2 Natasha Fazel, 1,2 and Dmitriy Scherbak 1,2,3 1 Sky Ridge Medical Center, 10099 RidgeGate Parkway, Lone Tree, CO 80124, USA 2 Rocky Vista University, 8401 South Chambers Rd, Parker, CO 80134, USA 3 Critical Care and Pulmonary Consultants, Denver, CO, 5200 DTC Parkway Suite 400, Greenwood Village, CO 80111, USA Correspondence should be addressed to Paula J. Watts; [email protected] Received 27 June 2018; Accepted 24 September 2018; Published 5 November 2018 Academic Editor: Tuuli Metsvaht Copyright © 2018 Paula J. Watts et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Neisseria meningitidis is a cause of bacterial meningitis and meningococcemia worldwide. Rarely, it causes invasive disease with significant lifelong sequela if survived. Early clinical recognition is key as meningococcemia is an easily treatable disease, yet mortality is 50% if it is leſt untreated. In this case review, we present a classic case of meningococcemia, with an atypical presentation. 1. Introduction Neisseria meningitidis is a gram-negative aerobic diplococcus, a cause of bacterial meningitis and meningococcemia world- wide [1]. It is a common bacterial commensal of the human nasopharynx with no animal reservoir [2, 3]. Its incidence differs drastically around the world, based on the serogroup virulence and host immune system [4]. In this article, we aim to present a case of meningococcemia presenting as flu-like symptoms complicated by shock and purpura fulminans. 2. Case Presentation A 61-year-old otherwise healthy Caucasian male presented to our institution with nonspecific, flu-like symptoms. e patient had been traveling with his wife to Austria, Switzer- land, and Germany the month prior to presentation. ey had taken a riverboat, had been in very close proximity to other people on the cruise, and there were multiple individuals who reportedly experienced similar symptoms. Upon return to the U.S., the patient’s symptoms had initially improved. However, they traveled to Creede, Colorado, where his symptoms then progressed approximately 4–16 days aſter potential exposure. Initially in the emergency department, the patient complained of malaise, dyspnea, chills, mild intermittent headache, and a fever. He quickly decompensated with high fevers, tachycardia, leukopenia, and a lactic acid of 7.69. Infectious etiology was considered likely. e patient was placed on broad-spectrum antibiotics; vancomycin, piperacillin/tazobactam, and levofloxacin, and given aggres- sive fluid resuscitation. He was admitted to the intensive care unit and within hours deteriorated further, requiring intubation, three vasopressors, and continuous renal replace- ment therapy. Within twelve hours, blood cultures returned positive for gram-negative diplococci, later identified as N. meningitidis W135 serotype. Over the subsequent hospital days, the patient went into disseminated intravascular coagulopathy (DIC) and progressed to purpura fulminans (PF). His clinical status did improve over the coming days and would eventually require bilateral transmetatarsal and digit amputations, as well as allograſt over these areas. 3. Discussion N. meningitidis occurs more oſten as epidemics with its largest burden found in sub-Saharan Africa and less so in developed countries [4]. It is seen in children and, more commonly, in young adults worldwide. e incubation period is between 2 and 14 days, commonly showing clinical signs by day 4 Hindawi Case Reports in Critical Care Volume 2018, Article ID 2097824, 3 pages https://doi.org/10.1155/2018/2097824

Upload: others

Post on 19-Oct-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

  • Case ReportMeningococcemia Masquerading as a NonspecificFlu-Like Syndrome

    Paula J. Watts ,1,2 Natasha Fazel,1,2 and Dmitriy Scherbak1,2,3

    1Sky Ridge Medical Center, 10099 RidgeGate Parkway, Lone Tree, CO 80124, USA2Rocky Vista University, 8401 South Chambers Rd, Parker, CO 80134, USA3Critical Care and Pulmonary Consultants, Denver, CO, 5200 DTC Parkway Suite 400, Greenwood Village, CO 80111, USA

    Correspondence should be addressed to Paula J. Watts; [email protected]

    Received 27 June 2018; Accepted 24 September 2018; Published 5 November 2018

    Academic Editor: Tuuli Metsvaht

    Copyright © 2018 Paula J. Watts et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Neisseria meningitidis is a cause of bacterial meningitis and meningococcemia worldwide. Rarely, it causes invasive disease withsignificant lifelong sequela if survived. Early clinical recognition is key as meningococcemia is an easily treatable disease, yetmortality is 50% if it is left untreated. In this case review,we present a classic case ofmeningococcemia, with an atypical presentation.

    1. Introduction

    Neisseriameningitidis is a gram-negative aerobic diplococcus,a cause of bacterial meningitis and meningococcemia world-wide [1]. It is a common bacterial commensal of the humannasopharynx with no animal reservoir [2, 3]. Its incidencediffers drastically around the world, based on the serogroupvirulence and host immune system [4]. In this article, we aimto present a case of meningococcemia presenting as flu-likesymptoms complicated by shock and purpura fulminans.

    2. Case Presentation

    A 61-year-old otherwise healthy Caucasian male presentedto our institution with nonspecific, flu-like symptoms. Thepatient had been traveling with his wife to Austria, Switzer-land, andGermany themonth prior to presentation.Theyhadtaken a riverboat, had been in very close proximity to otherpeople on the cruise, and there weremultiple individuals whoreportedly experienced similar symptoms.Upon return to theU.S., the patient’s symptoms had initially improved. However,they traveled to Creede, Colorado, where his symptoms thenprogressed approximately 4–16 days after potential exposure.

    Initially in the emergency department, the patientcomplained of malaise, dyspnea, chills, mild intermittent

    headache, and a fever. He quickly decompensated withhigh fevers, tachycardia, leukopenia, and a lactic acid of7.69. Infectious etiology was considered likely. The patientwas placed on broad-spectrum antibiotics; vancomycin,piperacillin/tazobactam, and levofloxacin, and given aggres-sive fluid resuscitation. He was admitted to the intensivecare unit and within hours deteriorated further, requiringintubation, three vasopressors, and continuous renal replace-ment therapy. Within twelve hours, blood cultures returnedpositive for gram-negative diplococci, later identified as N.meningitidis W135 serotype. Over the subsequent hospitaldays, the patient went into disseminated intravascularcoagulopathy (DIC) and progressed to purpura fulminans(PF). His clinical status did improve over the coming daysand would eventually require bilateral transmetatarsal anddigit amputations, as well as allograft over these areas.

    3. Discussion

    N.meningitidis occursmore often as epidemicswith its largestburden found in sub-Saharan Africa and less so in developedcountries [4]. It is seen in children and, more commonly, inyoung adults worldwide. The incubation period is between2 and 14 days, commonly showing clinical signs by day 4

    HindawiCase Reports in Critical CareVolume 2018, Article ID 2097824, 3 pageshttps://doi.org/10.1155/2018/2097824

    http://orcid.org/0000-0002-0017-7565https://creativecommons.org/licenses/by/4.0/https://doi.org/10.1155/2018/2097824

  • 2 Case Reports in Critical Care

    (a) (b)

    Figure 1: (a) Hospital day 9. Well-demarcated, large ecchymotic rash with multiple large bullae to the right lower extremity and hemorrhagicnecrosis to the distal digits and foot. (b) Hospital day 9. Necrosis involving the nasal supratip, tip, septum, and ala.

    [1, 2].There are 13 identified serotypes ofN.meningitidis; 6 areknown to cause epidemics and fatal disease: A, B, C, W135,X, and Y [1–3]. Serotypes are based on different capsularpolysaccharides. W135 is typically endemic to the Africanmeningitis belt [1, 3]. Roughly 10–20% of the population areasymptomatic carriers of N. meningitidis [2]. Exposure to ahypervirulent strain is responsible for pathogenicity [5].

    Clinical manifestation is variable. Meningitis alone fromN. meningitidis is the most common clinical manifestation.However, mild meningococcemia, shock with meningitis,and, rarely, shock without meningitis are other presentations.Severity is directly associated with bacterial load [5]. N.meningitidis is one of the most highly destructive etiologiesof septic shock due to its ability to cause PF and multiorganfailure.

    N. meningitidis spreads by droplets or direct contact.Its virulence is attributed to its ability to evade the innateimmune system via its cell wall attributes and ability touptake L-glutamate protecting it from phagocytic cells [5].It alters the surface of the endothelium when it adheresvigorously to cells, multiplies, and forms microcolonies. Indoing so, there is loss of capillary integrity, thrombosis, andhemorrhage, eventually causing PF. PF is a rapidly progressivefatal condition, which presents as the sudden appearance oflarge ecchymotic areas and progresses to acral skin necrosis(Figure 1). It involves intravascular thrombosis, cutaneousinfarction, and circulatory collapse.

    Meningococcal risk factors include close contacts orcrowding such as among college students and militaryrecruits living in close quarters, poor socioeconomic status,immunocompromised conditions such as terminal comple-ment pathway deficiency, human immunodeficiency virus

    infection, acquired complement deficiency, and splenic dys-function. [1, 4]. One’s risk is increased by other cofac-tors, which include smoking, coinfections with influenza,mycoplasma, or other upper respiratory tract infections [4].In our patient case, close crowding was potentially his onlyrisk factor while on a cruise. It is unlikely that he has aninherited or acquired complement deficiency based on hishistory, as he had been otherwise healthy, without recurrentinfections, liver or kidney dysfunction, or autoimmune dis-orders.

    If meningococcemia is suspected, a sample should beobtained immediately, either from a blood inoculate, cerebralspinal fluid, synovial fluid, pericardial fluid, or via skin biopsy[1]. This will confirm and facilitate rapid administrationof the appropriate treatment. Initiating antibiotics imme-diately, ideally after a lumbar puncture and cultures havebeen obtained, is crucial to the patient’s survival. Diagnos-tic procedures should never delay initiation of antibiotics.Penicillin G, ampicillin, 3𝑟𝑑-generation cephalosporins, andchloramphenicol are acceptable choices [1, 2]. However, dueto resistance, chloramphenicol is only used as empiric therapyin endemic areas [1]. The Center for Disease Control reportsa mortality rate of 8–15%, even with early diagnosis andtreatment, and up to 50% if left untreated [2]. A highawareness of this disease is imperative regardless of agesince clinical presentation is not always straightforward, asdemonstrated in this case report.

    Conflicts of Interest

    The authors have no conflicts of interest to report.

  • Case Reports in Critical Care 3

    References

    [1] S. Takada, S. Fujiwara, T. Inoue et al., “Meningococcemia inadults: A review of the literature,” Internal Medicine, vol. 55, no.6, pp. 567–572, 2016.

    [2] Centers for Disease Control and Prevention, “Meningococ-cal Meningitis, 2017,” Available from: http://www.who.int/mediacentre/factsheets/fs141/en/.

    [3] D. S. Stephens, B. Greenwood, and P. Brandtzaeg, “Epidemicmeningitis, meningococcaemia, and Neisseria meningitidis,”The Lancet, vol. 369, no. 9580, pp. 2196–2210, 2007.

    [4] D. S. Stephens, “Conquering themeningococcus,” FEMSMicro-biology Reviews, vol. 31, no. 1, pp. 3–14, 2007.

    [5] M. Coureuil, O. Join-Lambert, H. Lécuyer, S. Bourdoulous, S.Marullo, and X. Nassif, “Pathogenesis of meningococcemia,”Cold Spring Harbor Perspectives in Medicine, vol. 3, no. 6, 2013.

    http://www.who.int/mediacentre/factsheets/fs141/en/http://www.who.int/mediacentre/factsheets/fs141/en/

  • Stem Cells International

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    MEDIATORSINFLAMMATION

    of

    EndocrinologyInternational Journal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Disease Markers

    Hindawiwww.hindawi.com Volume 2018

    BioMed Research International

    OncologyJournal of

    Hindawiwww.hindawi.com Volume 2013

    Hindawiwww.hindawi.com Volume 2018

    Oxidative Medicine and Cellular Longevity

    Hindawiwww.hindawi.com Volume 2018

    PPAR Research

    Hindawi Publishing Corporation http://www.hindawi.com Volume 2013Hindawiwww.hindawi.com

    The Scientific World Journal

    Volume 2018

    Immunology ResearchHindawiwww.hindawi.com Volume 2018

    Journal of

    ObesityJournal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Computational and Mathematical Methods in Medicine

    Hindawiwww.hindawi.com Volume 2018

    Behavioural Neurology

    OphthalmologyJournal of

    Hindawiwww.hindawi.com Volume 2018

    Diabetes ResearchJournal of

    Hindawiwww.hindawi.com Volume 2018

    Hindawiwww.hindawi.com Volume 2018

    Research and TreatmentAIDS

    Hindawiwww.hindawi.com Volume 2018

    Gastroenterology Research and Practice

    Hindawiwww.hindawi.com Volume 2018

    Parkinson’s Disease

    Evidence-Based Complementary andAlternative Medicine

    Volume 2018Hindawiwww.hindawi.com

    Submit your manuscripts atwww.hindawi.com

    https://www.hindawi.com/journals/sci/https://www.hindawi.com/journals/mi/https://www.hindawi.com/journals/ije/https://www.hindawi.com/journals/dm/https://www.hindawi.com/journals/bmri/https://www.hindawi.com/journals/jo/https://www.hindawi.com/journals/omcl/https://www.hindawi.com/journals/ppar/https://www.hindawi.com/journals/tswj/https://www.hindawi.com/journals/jir/https://www.hindawi.com/journals/jobe/https://www.hindawi.com/journals/cmmm/https://www.hindawi.com/journals/bn/https://www.hindawi.com/journals/joph/https://www.hindawi.com/journals/jdr/https://www.hindawi.com/journals/art/https://www.hindawi.com/journals/grp/https://www.hindawi.com/journals/pd/https://www.hindawi.com/journals/ecam/https://www.hindawi.com/https://www.hindawi.com/